See more : PT Alumindo Light Metal Industry Tbk (ALMI.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Trupanion, Inc. (TRUP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trupanion, Inc., a leading company in the Insurance – Specialty industry within the Financial Services sector.
You may be interested
- Alphax Food System Co., Ltd (3814.T) Income Statement Analysis – Financial Results
- Morarjee Textiles Limited (MORARJEE.NS) Income Statement Analysis – Financial Results
- Winsome Resources Limited (WR1.AX) Income Statement Analysis – Financial Results
- ROCKELLE CORP (RKLC) Income Statement Analysis – Financial Results
- Tonner-One World Holdings, Inc. (TONR) Income Statement Analysis – Financial Results
Trupanion, Inc. (TRUP)
About Trupanion, Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11B | 905.18M | 698.99M | 502.03M | 383.94M | 303.96M | 242.67M | 188.23M | 146.96M | 115.91M | 83.83M | 55.53M | 37.05M |
| Cost of Revenue | 977.59M | 782.99M | 594.65M | 420.13M | 319.01M | 252.59M | 199.62M | 154.94M | 121.73M | 96.04M | 68.19M | 44.32M | 29.00M |
| Gross Profit | 131.02M | 122.19M | 104.35M | 81.90M | 64.92M | 51.37M | 43.05M | 33.29M | 25.23M | 19.87M | 15.64M | 11.21M | 8.04M |
| Gross Profit Ratio | 11.82% | 13.50% | 14.93% | 16.31% | 16.91% | 16.90% | 17.74% | 17.68% | 17.17% | 17.15% | 18.66% | 20.19% | 21.71% |
| Research & Development | 21.40M | 25.13M | 16.87M | 9.95M | 10.07M | 9.25M | 9.77M | 9.53M | 11.22M | 9.90M | 4.89M | 3.41M | 1.50M |
| General & Administrative | 60.21M | 39.38M | 31.89M | 21.85M | 20.97M | 18.16M | 16.82M | 15.21M | 15.56M | 14.31M | 8.65M | 6.20M | 4.29M |
| Selling & Marketing | 0.00 | 89.50M | 78.65M | 47.84M | 35.45M | 25.00M | 19.10M | 15.25M | 15.23M | 11.61M | 9.09M | 7.15M | 5.21M |
| SG&A | 60.21M | 128.88M | 110.54M | 69.68M | 56.42M | 43.16M | 35.92M | 30.45M | 30.79M | 25.92M | 17.74M | 13.34M | 9.50M |
| Other Expenses | 90.07M | 10.92M | 11.97M | 7.07M | 1.63M | 1.31M | 1.24M | -37.00K | 9.00K | 1.49M | -42.00K | -98.00K | -1.00K |
| Operating Expenses | 171.68M | 164.93M | 139.37M | 86.70M | 66.49M | 52.41M | 45.69M | 39.99M | 42.00M | 35.82M | 22.63M | 16.75M | 10.99M |
| Cost & Expenses | 1.15B | 947.93M | 734.02M | 506.83M | 385.50M | 305.00M | 245.31M | 194.93M | 163.74M | 131.86M | 90.82M | 61.07M | 40.00M |
| Interest Income | 0.00 | 3.00M | 10.00K | 1.38M | 1.35M | 0.00 | 0.00 | 119.00K | 75.00K | 73.00K | 86.00K | 75.00K | 69.00K |
| Interest Expense | 12.08M | 4.27M | 10.00K | 1.38M | 1.35M | 1.20M | 533.00K | 218.00K | 325.00K | 6.73M | 609.00K | 535.00K | 690.00K |
| Depreciation & Amortization | 12.47M | 10.92M | 11.97M | 7.07M | 5.63M | 4.51M | 4.23M | 3.85M | 2.54M | 1.67M | 892.00K | 349.00K | 199.00K |
| EBITDA | -20.48M | -29.01M | -23.25M | 2.73M | 5.34M | 4.78M | 2.83M | -2.79M | -14.22M | -12.78M | -6.77M | -5.44M | -2.94M |
| EBITDA Ratio | -1.85% | -3.20% | -3.33% | 0.54% | 1.39% | 1.57% | 1.17% | -1.47% | -9.68% | -11.03% | -7.28% | -9.39% | -7.25% |
| Operating Income | -40.66M | -42.75M | -35.03M | -4.35M | -291.00K | -1.05M | -2.64M | -6.70M | -16.78M | -15.95M | -6.99M | -5.54M | -2.95M |
| Operating Income Ratio | -3.67% | -4.72% | -5.01% | -0.87% | -0.08% | -0.34% | -1.09% | -3.56% | -11.41% | -13.76% | -8.33% | -9.97% | -7.97% |
| Total Other Income/Expenses | -4.38M | -1.20M | -24.00K | -800.00K | 280.00K | 111.00K | 711.00K | -160.00K | -316.00K | -5.24M | -1.28M | -787.00K | -876.00K |
| Income Before Tax | -45.04M | -44.20M | -35.22M | -5.73M | -1.64M | -934.00K | -1.93M | -6.86M | -17.09M | -21.18M | -8.27M | -6.33M | -3.83M |
| Income Before Tax Ratio | -4.06% | -4.88% | -5.04% | -1.14% | -0.43% | -0.31% | -0.80% | -3.64% | -11.63% | -18.28% | -9.86% | -11.39% | -10.33% |
| Income Tax Expense | -342.00K | 476.00K | 310.00K | 113.00K | 169.00K | -7.00K | -428.00K | 38.00K | 114.00K | -7.00K | -92.00K | 84.00K | 92.00K |
| Net Income | -44.69M | -44.67M | -35.53M | -5.84M | -1.81M | -927.00K | -1.50M | -6.90M | -17.21M | -21.18M | -8.18M | -6.41M | -3.92M |
| Net Income Ratio | -4.03% | -4.94% | -5.08% | -1.16% | -0.47% | -0.30% | -0.62% | -3.66% | -11.71% | -18.27% | -9.75% | -11.54% | -10.58% |
| EPS | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
| EPS Diluted | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
| Weighted Avg Shares Out | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
| Weighted Avg Shares Out (Dil) | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
truInsights into Pet Allergies: Trupanion Decodes Trends and Provides Tips for Pet Parents
SEATTLE--(BUSINESS WIRE)--As the number one most frequently claimed condition among Trupanion pet parents, allergies in pets are a topic of increasing priority for pet parents. With over 20 years of pet health data, Trupanion, Inc. (Nasdaq: TRUP), the leading provider...
Trupanion Introduces truInsights: A Pet Health Data Initiative
SEATTLE--(BUSINESS WIRE)--Trupanion (Nasdaq: TRUP), the leading provider of pet medical insurance, is proud to announce the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions...
5 Stocks From the Prospering Accident & Health Insurance Industry
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, EIG, AMSF and TRUP.
Trupanion, Inc. Announces First Quarter 2024 Earnings Release and Conference Call
SEATTLE, April 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 first quarter after the market closes on Thursday, May 2,...
Unleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big Returns
Two-thirds of American households own at least one pet, and large majorities of these pet owners view their companions as part of their families. Therefore, it's unsurprising that many households spend large amounts of money on their pets.
Trupanion Wins Silver Stevie® Award in 2024 Stevie Awards for Sales & Customer Service
SEATTLE--(BUSINESS WIRE)--Trupanion, Inc. (Nasdaq: TRUP) received the following awards at the 18th annual Stevie Awards for Sales & Customer Service: A Silver Stevie® Award in the Contact Center of the Year, Financial Services category A Silver Stevie® Award in the...
Trupanion Publishes 2023 Annual Letter to Shareholders
SEATTLE, April 16, 2024 (GLOBE NEWSWIRE) -- Trupanion , Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has published its 2023 annual shareholder letter, co-written by CEO and Chair, Darryl Rawlings, and President, Margi Tooth....
Trupanion Named 2024 Stevie® Awards Finalist for Three Sales & Customer Service Categories
SEATTLE--(BUSINESS WIRE)--Trupanion (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, was named a 2024 Stevie® Awards finalist in three Sales & Customer Service categories, solidifying Trupanion as a Gold, Silver, or Bronze Stevie Award winner in...
The Three Most Undervalued Pet Stocks to Buy in March 2024
In the flourishing pet care market, undervalued pet stocks are strategic choices for investors eyeing long-term portfolio expansion. These stocks latch onto the pet industry's powerful growth potential, marked by a 30% surge in global pet food sales from 2019...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trupanion Inc. - TRUP
NEW YORK , March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trupanion Inc. ("Trupanion" or the "Company") (NASDAQ: TRUP). Such investors are advised to contact Robert S.
Source: https://incomestatements.info
Category: Stock Reports